{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:12:02Z","timestamp":1783948322831,"version":"3.55.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Italian Ministry of Health","award":["PE-2011-02350284"],"award-info":[{"award-number":["PE-2011-02350284"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.beem.2018.06.008","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T13:00:15Z","timestamp":1529931615000},"page":"575-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Genetic causes and treatment of neonatal diabetes and early childhood diabetes"],"prefix":"10.1016","volume":"32","author":[{"given":"Fabrizio","family":"Barbetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D'Annunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.06.008_bib1","series-title":"The treatment of diabetes mellitus. With observations upon the disease based upon thirteen hundred cases","first-page":"52","article-title":"Exceptional cases in childhood","author":"Joslin","year":"2017"},{"key":"10.1016\/j.beem.2018.06.008_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/diab.24.1.44","article-title":"A\u00a0difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people","volume":"24","author":"Tattersall","year":"1975","journal-title":"Diabetes"},{"issue":"7892","key":"10.1016\/j.beem.2018.06.008_bib3","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","article-title":"Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies","volume":"2","author":"Bottazzo","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.06.008_bib4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/diacare.13.6.600","article-title":"Lessons learned from molecular biology of insulin-gene mutations","volume":"13","author":"Steiner","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib5","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/dc16-0645","article-title":"UNITED Team. Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes","volume":"39","author":"Shepherd","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib6","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2016-2490","article-title":"Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED). Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012","volume":"102","author":"Delvecchio","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.008_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00592-011-0331-8","article-title":"Minimal incidence of neonatal\/infancy onset diabetes in Italy is 1:90,000 live births","volume":"49","author":"Iafusco","year":"2012","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.beem.2018.06.008_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1399-5448.2011.00828.x","article-title":"Incidence, genetics and clinical phenotype of permanent neonatal diabetes mellitus in northwest Saudi Arabia","volume":"13","author":"Habeb","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib9","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the ATP-sensitive potassium channel subunit Kir6.2 gene are associated with permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.008_bib10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jc.2007-1826","article-title":"The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy","volume":"93","author":"Koster","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.008_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/db06-1275","article-title":"An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of DEND (Developmental Delay, Epilepsy, and Neonatal Diabetes)","volume":"56","author":"Masia","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib12","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","article-title":"Neonatal Diabetes International Collaborative Group. Insulin gene mutations as a cause of permanent neonatal diabetes","volume":"104","author":"St\u00f8y","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.06.008_bib13","first-page":"2148","article-title":"The Early onset diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (SIEDP). Seven mutations in the human insulin gene linked to permanent neonatal\/infancy-onset diabetes mellitus","volume":"118","author":"Colombo","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.06.008_bib14","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1073\/pnas.0910533107","article-title":"Recessive mutations in the insulin gene result in neonatal diabetes through reduced insulin biosynthesis","volume":"107","author":"Garin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.06.008_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2350-11-42","article-title":"Further evidence that mutations in INS can be a rare cause of Maturity Onset Diabetes of the Young (MODY)","volume":"11","author":"Boesgaard","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1096\/fj.03-1210fje","article-title":"Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice","volume":"18","author":"Zuber","year":"2004","journal-title":"FASEB"},{"key":"10.1016\/j.beem.2018.06.008_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11781","article-title":"How insulin engages its primary binding site on the insulin receptor","volume":"493","author":"Menting","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.beem.2018.06.008_bib18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db07-1405","article-title":"Insulin mutations screening in 1,044 patients with diabetes","volume":"57","author":"Edghill","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.008_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00125-011-2319-x","article-title":"Heterozygous ABCC8 mutations are a cause of MODY","volume":"55","author":"Bowman","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2018.06.008_bib21","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00125-011-2094-8","article-title":"The ISPED Early Diabetes Study Group. Permanent diabetes during the first year of life: multiple gene screening in 54 patients","volume":"54","author":"Russo","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2018.06.008_bib22","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)60098-8","article-title":"The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study","volume":"386","author":"De Franco","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.06.008_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ng.1035","article-title":"GATA6 haploinsufficiency causes pancreatic agenesis in humans","volume":"44","author":"Lango Allen","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2337\/db12-0885","article-title":"International NDM Consortium., Hattersley AT, Ellard S. GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine pancreatic insufficiency","volume":"62","author":"De Franco","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib25","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.2337\/db14-0061","article-title":"GATA4 mutations are a cause of neonatal and childhood diabetes","volume":"63","author":"Shaw-Smith","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nature08748","article-title":"Rfx6 direct islet formation and insulin production in mice and humans","volume":"463","author":"Smith","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.beem.2018.06.008_bib27","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.celrep.2014.11.033","article-title":"Rfx6 maintains the functional identity of adult pancreatic \u03b2 cells","volume":"9","author":"Piccard","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2018.06.008_bib28","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.celrep.2014.11.010","article-title":"RFX6 regulates insulin secretion by regulating Ca2+ homeostasis in human \u03b2 cells","volume":"9","author":"Chandra","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2018.06.008_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41467-017-00895-9","article-title":"Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance","volume":"8","author":"Patel","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2018.06.008_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0197-106","article-title":"Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence","volume":"15","author":"Stoffers","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib31","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.2337\/db10-0011","article-title":"Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities","volume":"59","author":"Rubio-Cabezas","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ng1097-138","article-title":"Early-onset type 2 diabetes mellitus (MODY) linked to IPF1","volume":"17","author":"Stoffers","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/15500","article-title":"Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus","volume":"23","author":"Malecki","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/cen.12541","article-title":"Maturity onset diabetes of the young in India \u2013 a distinctive mutation pattern identified through targeted next generation sequencing","volume":"82","author":"Chapla","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.06.008_bib35","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM200105243442104","article-title":"Neonatal diabetes mellitus due to complete glucokinase deficiency","volume":"344","author":"Nj\u00f8lstad","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.008_bib36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1530\/EJE-14-0852","article-title":"Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes form the South-Eastern region of Turkey: predominance of non-KATP channel mutations","volume":"172","author":"Demirbilek","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.008_bib37","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.2337\/dc14-1788","article-title":"Low prevalence of HNF1A mutations after molecular screening of multiple MODY genes in 58 Italian families recruited in the pediatric or adult diabetes clinic from a single Italian hospital","volume":"37","author":"Delvecchio","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib38","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db10-1008","article-title":"Permanent neonatal diabetes and enteric anendocrinosis associated with biallelic mutations in NEUROG3","volume":"60","author":"Rubio-Cabezas","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMoa054288","article-title":"Mutant neurogenin-3 in congenital malabsoprtive diarrhea","volume":"355","author":"Wang","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.008_bib40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ng1297-384","article-title":"Mutation in hepatocyte nuclear factor-1\u03b2 gene (TCF2) associated with MODY","volume":"17","author":"Horikawa","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7326\/0003-4819-140-7-200404060-00009","article-title":"Clinical spectrum associated with hepatocyte nuclear factor-1\u03b2 mutations","volume":"140","author":"Bellann\u00e9-Chatelot","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.06.008_bib42","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1210\/jc.2003-031828","article-title":"Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: phenotipically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism","volume":"89","author":"Yorifuji","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.008_bib43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/78085","article-title":"EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome","volume":"25","author":"Delepine","year":"2000","journal-title":"Nat Genet"},{"issue":"Suppl. 3","key":"10.1016\/j.beem.2018.06.008_bib44","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.2337\/diabetes.51.2007.S455","article-title":"Endoplasmic reticulum stress and the development of diabetes","volume":"51","author":"Harding","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.tem.2010.08.005","article-title":"PERK in beta cell biology and insulin biogenesis","volume":"21","author":"Cavener","year":"2010","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.06.008_bib46","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/ng1475","article-title":"Mutations in PTF1A cause pancreatic and cerebellar agenesis","volume":"36","author":"Sellick","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng.2826","article-title":"Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis","volume":"46","author":"Weedon","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cmet.2013.11.021","article-title":"Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man","volume":"19","author":"Flanagan","year":"2014","journal-title":"Cell Metabol"},{"key":"10.1016\/j.beem.2018.06.008_bib49","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ng1802","article-title":"Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism","volume":"38","author":"Sen\u00e9e","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajhg.2011.07.006","article-title":"Microcephaly with simplified gyration, epilepsy, and infantile diabetes linked to inappropriate apoptosis of neural progenitors","volume":"89","author":"Poulton","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1365-2141.2001.02774.x","article-title":"A\u00a0novel mutation in the SLC19A2 gene in a Tunisian family with thiamine responsive megaloblastic anemia, diabetes and deafness syndrome","volume":"116","author":"Gritli","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beem.2018.06.008_bib52","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00125-012-2595-0","article-title":"SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion","volume":"55","author":"Sansbury","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2018.06.008_bib53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0295-110","article-title":"An imprinted gene(s) for diabetes","volume":"9","author":"Temple","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng.187","article-title":"Hypomethylation of multiple loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57","volume":"40","author":"Mackay","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib55","doi-asserted-by":"crossref","first-page":"F341","DOI":"10.1136\/adc.2003.030502","article-title":"An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission","volume":"89","author":"Shield","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.beem.2018.06.008_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib57","series-title":"Diabetes associated with single gene defects and chromosomal abnormalities","article-title":"Type 1 diabetes mellitus in monogenic autoimune disease","author":"Bacchetta","year":"2017"},{"key":"10.1016\/j.beem.2018.06.008_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2018.00098","article-title":"Twenty years of AIRE","volume":"9","author":"Perniola","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.beem.2018.06.008_bib59","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.2337\/db17-0040","article-title":"Recessively inherited LRBA mutations cause autoimmunity presenting as neonatal diabetes","volume":"66","author":"Johnson","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib60","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1210\/jc.2015-3382","article-title":"Infancy-onset T1D, short stature, severe immunodysregulation, in two siblings with homozygous LRBA mutation","volume":"101","author":"Schreiner","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.008_bib61","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multiorgan autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.celrep.2017.03.055","article-title":"An activating STAT3 mutation causes neonatal diabetes through premature induction of pancreatic differentiation","volume":"19","author":"Saarim\u00e4ki-Vire","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2018.06.008_bib63","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beem.2018.06.008_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/2441","article-title":"A\u00a0gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy","volume":"20","author":"Inoue","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/humu.10258","article-title":"Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease","volume":"22","author":"Cryns","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.06.008_bib66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jmg.2005.034892","article-title":"Autosomal dominant optic atrophy associated with hearing impairment, and impaired glucose regulation caused by a missense mutation in the WFS1 gene","volume":"43","author":"Eiberg","year":"2006","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib67","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.2337\/db13-0571","article-title":"Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation","volume":"62","author":"Bonnycastle","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib68","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/pedi.12513","article-title":"A\u00a0novel heterozygous mutation of the WFS1 gene leading to constitutive endoplasmic reticulum stress is the cause of Wolfram syndrome","volume":"18","author":"Morikawa","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib69","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1093\/hmg\/ddn304","article-title":"WFS1 mutations are frequent monogenic cause of juvenile-onset diabetes mellitus in Lebanon","volume":"17","author":"Zalloua","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib70","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/db13-0717","article-title":"\u03b2-cell dysfunction due to increased ER-stress in a stem-cell model of Wolfram syndrome","volume":"63","author":"Shang","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib71","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/520961","article-title":"A\u00a0homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2","volume":"81","author":"Amr","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2350-15-88","article-title":"A\u00a0novel CISD2 intragenic deletion, optic neuropathy and platelet aggregation defect in Wolfram syndrome type 2","volume":"15","author":"Mozzillo","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12881-017-0508-2","article-title":"A\u00a0donor splice site mutation in CISD2 generates multiple truncated, non-functional isoforms in Wolfram syndrome type 2 patients","volume":"18","author":"Cattaneo","year":"2017","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib74","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddx060","article-title":"A\u00a0novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alter Ca2+ homeostasis and ER-mitochondria interactions","volume":"26","author":"Rouzier","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib75","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41419-018-0406-3","article-title":"Wolfram syndrome: MAMs' connection","volume":"9","author":"Delprat","year":"2018","journal-title":"Cell Death Dis"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2018.06.008_bib76","first-page":"S101","article-title":"Beta-cell genes and diabetes: molecular and clinical characterization in transcription factors","volume":"50","author":"Frayling","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib77","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/db07-0859","article-title":"The type and position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3","volume":"57","author":"Bellann\u00e9-Chantelot","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2337\/diacare.26.2.333","article-title":"Identifying hepatic nuclear factor 1alpha mutations in children and young adults with clinical diagnosis of type 1 diabetes","volume":"26","author":"Lambert","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib79","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2337\/dc11-0323","article-title":"High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes","volume":"34","author":"McDonald","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib80","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2337\/dc08-2018","article-title":"Italian Society of Pediatric Endocrinology and Diabetology [ISPED] Study Group. Maturity onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families","volume":"32","author":"Lorini","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib81","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s001250050931","article-title":"Chronic diabetic complications in patients with MODY3 diabetes","volume":"41","author":"Isomaa","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2018.06.008_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1464-5491.2009.02913.x","article-title":"Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutation in the HNF1A gene","volume":"27","author":"Steele","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.beem.2018.06.008_bib83","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/dme.12992","article-title":"Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort","volume":"33","author":"Bacon","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.beem.2018.06.008_bib84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/B978-0-12-800174-5.00016-8","article-title":"Roles of HNF1\u03b1 and HNF4\u03b1 in pancreatic \u03b2-cells: lessons from a monogenic form of diabetes","volume":"95","author":"Yamagata","year":"2014","journal-title":"Vitam Horm"},{"key":"10.1016\/j.beem.2018.06.008_bib85","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1371\/journal.pmed.0040118","article-title":"Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene","volume":"4","author":"Pearson","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.beem.2018.06.008_bib86","first-page":"352","article-title":"Macrosomia, transient neonatal hypoglycemia and monogenic diabetes in a family with heterozygous mutation R154X of HNF4A","volume":"34","author":"Colombo","year":"2011","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2018.06.008_bib87","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00125-016-4167-1","article-title":"Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry","volume":"60","author":"Johansson","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2018.06.008_bib88","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1073\/pnas.0409177102","article-title":"Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function","volume":"102","author":"Neve","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2018.06.008_bib89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng1708","article-title":"Mutations in CEL VNTR cause a syndrome of diabetes and pancreatic exocrine function","volume":"38","author":"Raeder","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2018.06.008_bib90","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1210\/jc.2006-1927","article-title":"Pax mutations in Thais with maturity onset diabetes of the young","volume":"92","author":"Plengvidhya","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.008_bib91","doi-asserted-by":"crossref","first-page":"14460","DOI":"10.1073\/pnas.0906474106","article-title":"Mutations at the BLK locus linked to maturity onset diabetes of the young and \u03b2-cell dysfunction","volume":"106","author":"Borowiec","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2018.06.008_bib92","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1056\/NEJM199404073301403","article-title":"A\u00a0subtype of diabetes mellitus associated with a mutation of mitochondrial DNA","volume":"330","author":"Kadowaki","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.008_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pedi.12223","article-title":"The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes","volume":"16","author":"Karaa","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib94","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2012.01.018","article-title":"Pearson syndrome: unique endocrine manifestation including neonatal diabetes and adrenal insufficiency","volume":"106","author":"Williams","year":"2012","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.beem.2018.06.008_bib95","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00592-013-0490-x","article-title":"Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor. Is it a Bartter-like syndrome a feature of congenital SIR","volume":"50","author":"Grasso","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.beem.2018.06.008_bib96","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/pedi.12508","article-title":"Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated disease","volume":"18","author":"Tsuji-Hosokawa","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib97","article-title":"Clinical characteristic of adolescent cases with type A insulin resistance syndrome caused by heterozygous mutations in the \u03b2-subunit of INSR","author":"Takasawa","year":"2018","journal-title":"J\u00a0Diabetes"},{"issue":"4 Spec no","key":"10.1016\/j.beem.2018.06.008_bib98","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/adc.67.4_Spec_No.357","article-title":"Patterns of metabolic adaptation for preterm and term infants in the first neonatal week","volume":"67","author":"Hawdon","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.beem.2018.06.008_bib99","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000381621","article-title":"Differentiating transient idiopathic hyperglycaemia and neonatal diabetes mellitus in preterm infants","volume":"84","author":"Busiah","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.beem.2018.06.008_bib100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ccr3.1276","article-title":"Neonatal diabetes mellitus: improved screening and early management of an underestimated disease","volume":"6","author":"Wirth","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.beem.2018.06.008_bib101","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/pedi.12481","article-title":"Glycemic control indicator levels at diagnosis of neonatal diabetes mellitus: comparison with other types of diabetes mellitus","volume":"18","author":"Suzuki","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.beem.2018.06.008_bib102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pediatrneurol.2014.04.015","article-title":"Effects of hyperglycemia on the developing brain in newborns","volume":"51","author":"Tayman","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.beem.2018.06.008_bib103","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fnins.2017.00529","article-title":"Type 1 diabetes and impaired awareness of hypoglycemia are associated with reduced brain gray matter volumes","volume":"11","author":"Bednarik","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.beem.2018.06.008_bib104","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(13)70059-7","article-title":"French NDM study group. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study","volume":"1","author":"Busiah","year":"2013","journal-title":"Lancet Diab Endocrinol"},{"key":"10.1016\/j.beem.2018.06.008_bib105","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2337\/dc15-0837","article-title":"GlidKir Study Group. Sulfonylurea therapy benefits neurological and psychomotor functions in patients with neonatal diabetes owing to potassium channel mutations","volume":"38","author":"Beltrand","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib106","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.2337\/dc17-1145","article-title":"Diabetes presentation in infancy: high risk of diabetic ketoacidosis","volume":"40","author":"Letourneau","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib107","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.diabres.2017.04.007","article-title":"Insulin therapy in neonatal diabetes mellitus: a review of the literature","volume":"129","author":"Rabbone","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.beem.2018.06.008_bib108","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrendo.2011.204","article-title":"Management of diabetes mellitus in infants","volume":"8","author":"Karges","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2018.06.008_bib109","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00592-015-0793-1","article-title":"Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment","volume":"53","author":"Ortolani","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.beem.2018.06.008_bib110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/dia.2014.0055","article-title":"Treatment of transient neonatal diabetes mellitus: insulin pump or insulin glargine? Our experience","volume":"16","author":"Passanisi","year":"2014","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.beem.2018.06.008_bib111","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/dia.2015.0339","article-title":"Use of insulin pump in neonates and toddlers","volume":"17","author":"Klingensmith","year":"2015","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.beem.2018.06.008_bib112","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2337\/diaspect.29.3.176","article-title":"A\u00a0novel approach to the management of neonatal diabetes using sensor-augmented insulin pump therapy with threshold suspend technology at diagnosis","volume":"29","author":"Marin","year":"2016","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.beem.2018.06.008_bib113","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00592-015-0828-7","article-title":"Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis","volume":"53","author":"Rabbone","year":"2016","journal-title":"Acta Diabetol"},{"issue":"3","key":"10.1016\/j.beem.2018.06.008_bib114","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40748-017-0055-z","article-title":"Continuous glucose monitoring in neonates: a review","volume":"17","author":"McKinlay","year":"2017","journal-title":"Maternal Health Neonatol Perinatol"},{"key":"10.1016\/j.beem.2018.06.008_bib115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"35","author":"Pearson","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.008_bib116","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00125-006-0329-x","volume":"49","author":"Tonini","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2018.06.008_bib117","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/dom.13085","article-title":"Primary sulphonylurea therapy in a newborn with transient neonatal diabetes attributable to a paternal uniparental disomy 6q24 [UPD6]","volume":"20","author":"Neumann","year":"2018","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.beem.2018.06.008_bib118","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4274\/jcrpe.5166","article-title":"A\u00a0novel KCNJ11 mutation associated with transient neonatal diabetes","volume":"10","author":"Gole","year":"2018","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.beem.2018.06.008_bib119","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/JPEM.2005.18.11.1095","article-title":"Neonatal diabetes mellitus: patient reports and review of current knowledge and clinical practice","volume":"18","author":"Jeha","year":"2005","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.008_bib120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2431-14-188","article-title":"Permanent neonatal diabetes mellitus in China","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.beem.2018.06.008_bib121","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology-drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.008_bib122","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1754.2005.00696.x","article-title":"Neonatal diabetes mellitus: insulin pump as an alternative management strategy","volume":"41","author":"Bharucha","year":"2005","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.beem.2018.06.008_bib123","first-page":"57","article-title":"Insulin pump therapy in children and adolescents with type 1 diabetes: the Italian viewpoint","volume":"79","author":"Pinelli","year":"2008","journal-title":"Acta Biomed"},{"key":"10.1016\/j.beem.2018.06.008_bib124","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/dia.2013.0357","article-title":"Continuous subcutaneous insulin infusion in preschool children: butt or tummy, which is the best infusion set site?","volume":"16","author":"Zanfardino","year":"2014","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.beem.2018.06.008_bib125","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/dme.13294","article-title":"Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study","volume":"34","author":"Rabbone","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/j.beem.2018.06.008_bib126","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2337\/dc12-2166","article-title":"Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11mutations results in improved cerebellar perfusion","volume":"36","author":"Fendler","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib127","doi-asserted-by":"crossref","first-page":"108274","DOI":"10.18632\/oncotarget.22548","article-title":"Sulfonylurea for the treatment of neonatal diabetes owing to KATP-channel mutations: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.beem.2018.06.008_bib128","doi-asserted-by":"crossref","first-page":"E2709","DOI":"10.1210\/jc.2014-2494","article-title":"Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons","volume":"99","author":"Carmody","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.008_bib129","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00125-016-3921-8","article-title":"Successful transfer to sulphonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes","volume":"59","author":"Babiker","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2018.06.008_bib130","unstructured":"Hattersley AT. Transferring Patients with Diabetes due to KIR6.2 Mutation from Insulin to Sulphonylurea: Providing Information for Patients and Professionals on Research and Clinical Care in Genetic types of Diabetes. Available from: www.diabetesgenes.org\/content\/transferring-patients-diabetes-due-kir6.2-mutation-insulin-sulphonylureas"},{"key":"10.1016\/j.beem.2018.06.008_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30106-2","article-title":"For the Neonatal Diabetes International Collaborative Group. Long-term treatment with sulfonylureas is highly effective and safe in neonatal diabetes due to KCNJ11 mutations: an international cohort study","author":"Bowman","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2018.06.008_bib132","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00125-017-4226-2","article-title":"Precision diabetes: learning from monogenic diabetes","volume":"60","author":"Hatterlsey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2018.06.008_bib133","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","article-title":"Genetic cause of hyperglycaemia and response to treatment in diabetes","volume":"362","author":"Pearson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.06.008_bib134","doi-asserted-by":"crossref","DOI":"10.2337\/dc18-0384","article-title":"Mexican carriers of the HNF1A p.E508K variant do not experience an enhanced response to sulfonylureas","author":"Martag\u00f3n","year":"2018","journal-title":"Diabetes Care"},{"issue":"133","key":"10.1016\/j.beem.2018.06.008_bib135","doi-asserted-by":"crossref","first-page":"e775","DOI":"10.1542\/peds.2012-2537","article-title":"Metiglinide analogues in adolescent patients with HNF1A-MODY (MODY3)","volume":"2014","author":"Becker","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2018.06.008_bib136","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2337\/dc13-3007","article-title":"Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized crossover trial","volume":"37","author":"\u00d8stoft","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2018.06.008_bib137","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000356925","article-title":"A\u00a0family with a novel termination mutation in hepatic nuclear-factor 1a in a maturity-onset diabetes of the young type 3 which is unresponsive to sulphonylurea therapy","volume":"81","author":"Demol","year":"2014","journal-title":"Horm Res Paediatr"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:54:38Z","timestamp":1761497678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18300903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":137,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1521690X18300903"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.06.008","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic causes and treatment of neonatal diabetes and early childhood diabetes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}